FDA Investigator Humera Khan
Humera Khan has inspections in 1 countries as of 01 Aug 2023. Humera Khan has collaborated with a combined 1807 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alicia M Mozzachio,
Amanda Dinaro,
Amanda S Zorn,
Ann Marie Montemurro,
Ann Marie Schofield,
Anna Flynn,
Ashley L Reiber,
Barry Cherney, PhD,
Brentley S Collins,
Brian D Nicholson,
Bruce H Mccullough,
Burnell M Henry,
Carrie Ann Plucinski,
Chad E Schmear,
Chiang Syin, PhD,
Christina A Miller,
Christina V Santos,
Claire M Minden,
Daniel C Kearns,
Daniel Kearns,
David Perkins,
Deborah M Trout,
Debra Boyd Seale,
Debra I Love,
Debra L Boyd Seale,
Dr. Andrew Shroke,
Dr. Guang Gao, PhD,
Eliezar Ramos,
Elliot P Cowam, PhD,
Eric M Mueller, PharmD,
Gene D Arcy,
Gregory Price,
Harperd,
Helen B Ricalde,
Humera T Khan,
Jacqueline Mdiaz Albertini,
James W Plucinski,
Jan B Welch,
Jan Welch,
Jason F Chancey,
Jeanne M Morris,
Jennifer L Schmidt,
Jesse A Vazquez,
Joan A Loreng,
John M Seale,
Joseph A Morkunas,
Julie D Bringger,
Karen Emasley Joseph,
Karen Emaslwey Joseph,
Kathleen B Swat,
Kimberly Lewandowski Walker,
Kujtim Sadiku,
Lagurta M Mayher,
Lakisha M Williams,
Laura Fontan, MS,
Laurie A Haxel,
LCDR Debra Emerson,
LCDR Randall L Morris,
Lequita M Mayhew,
Lisa Hornback,
Lisa M Bellows,
Lisa M Feola,
Lorelei S Jarrell,
Margaret Mtorres Vazquez,
Margaret Torres Vazquez,
Martha T Olone,
Maureen C Melvin,
Michael D Robinson,
Mihaly S Ligmond,
Nicholas F Lyons,
Nicholas P Diorio,
Nicole J Clausen,
Nicole K Trudel,
Nicole S Williams,
Norman Wong,
Omotunde O Osunsanmi,
Paula A Trost,
Phung Thien Nguyen,
Prabhu P Raju,
Rafael Padilla,
Ralph A Erickson,
Rebecca K Olin,
Richard Heath Coats,
Richard T Riggie,
Robert L Stevenson,
Roberta W Cunningham,
Rona Leblanc, PhD,
Russ R Rivy,
Russell K Riley,
Samuel W Labinjo,
Sarah B Tanksley,
Sean R Bryd,
Stephen D Brown,
Stephen D Eich,
Susan A Zullo, PhD,
Susan M Jackson,
Susan P Bruederle,
Tamara Brey,
Todd M Stankewicz,
Unnee Ranjan,
Yonggang Wang, PhD
Humera Khan's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2000 | FDA 483 Response | Abbott Laboratories - Form 483R, 2000-04-13 |
April, 2000 | FDA 483 Response | Abbott Laboratories - Form 483R, 2000-08-28 |
April, 2003 | EIR | CSL Behring L.L.C. - EIR, 2003-04-01 |
April, 2003 | FDA 483 | CSL Behring L.L.C. - Form 483, 2003-04-01 |
June, 2000 | EIR | AbbVie Inc. - EIR, 2000-06-19 |
April, 2000 | FDA 483 | Abbott Laboratories - Form 483, 2000-03-31 |
April, 2000 | EIR | Abbott Laboratories - EIR, 2000-03-31 |
April, 2000 | EIR | Abbott Laboratories - EIR, 2000-04-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more